Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
90.01 CHF | +1.00% | +6.47% | +6.03% |
Apr. 24 | BMO Capital Adjusts Price Target on Novartis to $116 From $114, Maintains Market Perform Rating | MT |
Apr. 24 | Novartis Says New Malaria Drug Formulation Safe and Effective for Babies | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.03% | 199B | |
+23.82% | 562B | |
-6.41% | 358B | |
+18.65% | 322B | |
+7.09% | 297B | |
+13.19% | 219B | |
-10.27% | 196B | |
-10.94% | 149B | |
-6.94% | 146B | |
+2.15% | 117B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Novartis Mulling Sale of Ophthalmology, Respiratory Units